Khrom Capital Management LLC (“Khrom Capital”), which together with its investment funds and affiliates, owns 5.5% of Acadia Healthcare Company, Inc. (Nasdaq: ACHC) (“Acadia” or the “Company”) and is one of the Company’s largest shareholders, today sent a letter to the Company’s Board of Directors reiterating its belief that the Company should pursue a formal review of strategic alternatives, including a sale, in order to maximize value for its shareholders.
The letter can be downloaded here.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.